Digestive Diseases and Sciences

, Volume 55, Issue 8, pp 2337–2343 | Cite as

Does Level of Sedation Impact Detection of Advanced Neoplasia?

  • A. Wang
  • K. M. Hoda
  • J. L. Holub
  • G. M. Eisen
Original Article


Background and Aims

Two of the foremost issues in screening colonoscopy involve delivering quality and maximizing adenoma detection rates (ADR). Little is known about the impact of deep sedation on ADR. This study aims to compare the detection of advanced lesions during screening colonoscopy performed with moderate conscious sedation (MCS) versus deep sedation (DS).


A retrospective cohort study was performed using the Clinical Outcomes Research Initiative database. Average risk screening colonoscopies performed January 2000 to December 2005 were examined for practice setting, patient demographics, and findings, including detection of a polyp >9 mm and suspected malignant lesions.


A total of 104,868 colonoscopies were examined, 97% of which were performed with MCS. Univariate analysis demonstrated that more polyps of any size were detected with MCS (38 vs. 34%, p < 0.0001) and more advanced lesions were found with DS compared with MCS (7 vs. 6%, p = 0.01). When exclusively examining sites that performed DS > 10% for all procedures, a more significant increase in advanced lesion detection when using DS was observed (7.5 vs. 5.7%, p = 0.003). When adjusted for age, gender, race/ethnicity, site, prep quality, and ASA group, DS was 25% more likely to detect an advanced lesion.


Our data suggest that use of DS may be associated with a higher rate of advanced lesion detection. However, this retrospective design has limitations that necessitate follow-up with prospective studies. These follow-up studies would be essential to support any change in the standard practices of sedation.


Colonoscopy Deep sedation Advanced neoplasia Propofol Polyp 



Adenoma detection rate


America Society of Anesthesiologists


Clinical outcomes research initiative


Confidence interval


Deep sedation


Moderate conscious sedation


National endoscopic database




Odds ratio



This project was supported with funding from NIDDK UO1 CA 89389-01 and R33-DK61778-01. In addition, the practice network (CORI) has received support from the following entities to support the infrastructure of the practice-based network: AstraZeneca, Bard International, Pentax USA, ProVation, Endosoft, GIVEN Imaging, and Ethicon. The commercial entities had no involvement in this research. GE is the executive co-director of CORI, a nonprofit organization that receives funding from federal and industry sources. This potential conflict of interest has been reviewed and managed by the Oregon Health and Science University (OHSU) Conflict of Interest in Research Committee.


  1. 1.
    Gross CP, Andersen MS, Krumholz HM. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296:2815–2822.CrossRefPubMedGoogle Scholar
  2. 2.
    Hardcastle JD, Chamberlain JO, Robinson MH. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.CrossRefPubMedGoogle Scholar
  3. 3.
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.CrossRefPubMedGoogle Scholar
  4. 4.
    Mandel JS, Church TR, Bond JH. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.CrossRefPubMedGoogle Scholar
  5. 5.
    Winawer SJ, Zauber AG, Ho MN. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–1981.CrossRefPubMedGoogle Scholar
  6. 6.
    Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adenomas missed by optical colonoscopy. Ann Intern Med. 2004;141:352–359.PubMedGoogle Scholar
  7. 7.
    Rex DK, Cutler CS, Lemmel GT. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24–28.CrossRefPubMedGoogle Scholar
  8. 8.
    Chen S, Rex DK. Endoscopist is comparable to age and gender as predictor of adenomas at colonoscopy. Am J Gastroenterol. 2005;100:S393.Google Scholar
  9. 9.
    Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc. 2003;58:76–79.CrossRefPubMedGoogle Scholar
  10. 10.
    Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel on Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc. 2005;61:378–384.CrossRefPubMedGoogle Scholar
  11. 11.
    Sonnenberg A, Amorosi SL, Lacey MJ, Lieberman DA. Patterns of endoscopy in the United States: analysis of data from the centers for Medicare and Medicaid services and the national endoscopic database. Gastrointest Endosc. 2008;67:489–496.PubMedGoogle Scholar
  12. 12.
    Lieberman D, Moravec M, Holub J, Michaels L, Eisen G. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology. 2008;135:1100–1105.CrossRefPubMedGoogle Scholar
  13. 13.
    Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc. 2005;62:875–883.CrossRefPubMedGoogle Scholar
  14. 14.
    Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol. 2005;3:798–805.CrossRefPubMedGoogle Scholar
  15. 15.
    Lieberman DA, Holub JL, Moravec MD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1417–1422.CrossRefPubMedGoogle Scholar
  16. 16.
    Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc. 2007;99:723–728.PubMedGoogle Scholar
  17. 17.
    Agrawal S, Bhupinderjit A, Bhutani MS. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515–523. (discussion 514).CrossRefPubMedGoogle Scholar
  18. 18.
    Schoenfeld P, Cash B, Flood A. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005;352:2061–2068.CrossRefPubMedGoogle Scholar
  19. 19.
    Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006;355:2533–2541.CrossRefPubMedGoogle Scholar
  20. 20.
    Barclay RL, Vicari JJ, Greenlaw RL. Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol. 2008;6:1091–1098.CrossRefPubMedGoogle Scholar
  21. 21.
    Imperiale TF, Wagner DR, Lin CY. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–174.CrossRefPubMedGoogle Scholar
  22. 22.
    Lieberman DA, Weiss DG, Bond JH. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–168.CrossRefPubMedGoogle Scholar
  23. 23.
    Aisenberg J, Brill JV, Ladabaum U, Cohen LB. Sedation for gastrointestinal endoscopy: new practices, new economics. Am J Gastroenterol. 2005;100:996–1000.CrossRefPubMedGoogle Scholar
  24. 24.
    Chen SC, Rex DK. Variable detection of nonadenomatous polyps by individual endoscopists at colonoscopy and correlation with adenoma detection. J Clin Gastroenterol. 2008;42:704–707.CrossRefPubMedGoogle Scholar
  25. 25.
    Bird CL, Frankl HD, Lee ER, Haile RW. Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol. 1998;147:670–680.PubMedGoogle Scholar
  26. 26.
    Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomark Prev. 2001;10:725–731.Google Scholar
  27. 27.
    Giovannucci E, Rimm EB, Ascherio A. Alcohol, low-methionine–low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87:265–273.CrossRefPubMedGoogle Scholar
  28. 28.
    Kim JH, Lim YJ, Kim YH. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomark Prev. 2007;16:1543–1546.CrossRefGoogle Scholar
  29. 29.
    Neugut AI, Lee WC, Garbowski GC. Obesity and colorectal adenomatous polyps. J Natl Cancer Inst. 1991;83:359–361.CrossRefPubMedGoogle Scholar
  30. 30.
    Paskett ED, Reeves KW, Rohan TE. Association between cigarette smoking and colorectal cancer in the women’s health initiative. J Natl Cancer Inst. 2007;99:1729–1735.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • A. Wang
    • 1
  • K. M. Hoda
    • 1
  • J. L. Holub
    • 1
  • G. M. Eisen
    • 1
  1. 1.Department of GastroenterologyOregon Health and Science UniversityPortlandUSA

Personalised recommendations